Commentary: Outcomes of Metaplastic Breast Cancer vs. Triple-Negative Breast Cancer
-
Published:2023-09-30
Issue:12
Volume:47
Page:3203-3204
-
ISSN:0364-2313
-
Container-title:World Journal of Surgery
-
language:en
-
Short-container-title:World J Surg
Author:
Agarwal GauravORCID,
Chanthar K. M. M. Vishvak
Reference5 articles.
1. Tan YuPing, Yang B, Chen YuHong et al (2023) Outcomes of metaplastic breast cancer versus triple-negative breast cancer: a propensity score matching analysis. World J Surg. https://doi.org/10.1007/s00268-023-07106-1
2. Luini A, Aguilar M, Gatti G et al (2007) Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European institute of oncology and review of the literature. Breast Cancer Res Treat 101(3):349–353 ([PubMed: 17009109])
3. El Zein D, Hughes M, Kumar S et al (2017) Metaplastic carcinoma of the breast is more aggressive than triple-negative breast cancer: a study from a single institution and review of literature. Clin Breast Cancer 17(5):382–391. https://doi.org/10.1016/j.clbc.2017.04.009
4. Lester TR, Hunt KK, Nayeemuddin KM et al (2012) Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers. Breast Cancer Res Treat 131:41–48 ([PubMed: 21331622])
5. Agarwal G, Vishvak Chanthar KMM, Katiyar S et al (2023) Predictive and prognostic role of tumor-infiltrating lymphocytes in patients with advanced breast cancer treated with primary systemic therapy. World J Surg 47(5):1238–1246. https://doi.org/10.1007/s00268-023-06912-x. (Epub 2023 Feb 3 PMID: 36735048)